D
NeuroPace, Inc. NPCE
$8.42 -$0.14-1.64% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -15.13% 26.17% 15.32% 24.87% 17.65%
Total Depreciation and Amortization 7.43% 9.22% 10.27% 13.32% 10.17%
Total Amortization of Deferred Charges 1.85% -37.18% -35.53% -36.49% -21.74%
Total Other Non-Cash Items 13.61% -16.23% -6.72% -19.00% -1.25%
Change in Net Operating Assets 694.60% -65.19% -277.74% -53.24% -145.13%
Cash from Operations 46.51% 0.61% -43.58% 25.11% 10.55%
Capital Expenditure -166.67% 64.42% -21.88% -1,011.11% --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -42.86% -64.29% -37.74%
Cash from Investing -105.19% -101.54% -43.45% -66.60% -38.92%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -64.72% 9,731.07% -88.86% 36,975.00% 137.14%
Repurchase of Common Stock -141.67% -7,569.34% -148.65% -94.29% -75.61%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -474.85% 29,216.67% -89.68% 10,833.33% 161.03%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -2,602.60% 368.56% -123.83% 38.24% -113.57%